Epidemiological Evidence for Lineage-Specific Differences in the Risk of Inapparent Chikungunya Virus Infection
- PMID: 30463967
- PMCID: PMC6364014
- DOI: 10.1128/JVI.01622-18
Epidemiological Evidence for Lineage-Specific Differences in the Risk of Inapparent Chikungunya Virus Infection
Abstract
In late 2013, chikungunya virus (CHIKV) was introduced into the Americas, leading to widespread epidemics. A large epidemic caused by the Asian chikungunya virus (CHIKV) lineage occurred in Managua, Nicaragua, in 2015. Literature reviews commonly state that the proportion of inapparent CHIKV infections ranges from 3 to 28%. This study estimates the ratio of symptomatic to asymptomatic CHIKV infections and identifies risk factors of infection. In October to November 2015, 60 symptomatic CHIKV-infected children were enrolled as index cases and prospectively monitored, alongside 236 household contacts, in an index cluster study. Samples were collected upon enrollment and on day 14 or 35 and tested by real-time reverse transcription-PCR (rRT-PCR), IgM capture enzyme-linked immunosorbent assays (IgM-ELISAs), and inhibition ELISAs to detect pre- and postenrollment CHIKV infections. Of 236 household contacts, 55 (23%) had experienced previous or very recent infections, 41 (17%) had active infections at enrollment, and 21 (9%) experienced incident infections. Vehicle ownership (multivariable-adjusted risk ratio [aRR], 1.58) increased the risk of CHIKV infection, whereas ≥4 municipal trash collections/week (aRR, 0.38) and having externally piped water (aRR, 0.52) protected against CHIKV infection. Among 63 active and incident infections, 31 (49% [95% confidence interval {CI}, 36%, 62%]) were asymptomatic, yielding a ratio of symptomatic to asymptomatic infections of 1:0.97 (95% CI, 1:0.56, 1:1.60). Although our estimate is outside the 3% to 28% range reported previously, Bayesian and simulation analyses, informed by a systematic literature search, suggested that the proportion of inapparent CHIKV infections is lineage dependent and that more inapparent infections are associated with the Asian lineage than the East/Central/South African (ECSA) lineage. Overall, these data substantially improve knowledge regarding chikungunya epidemics.IMPORTANCE Chikungunya virus (CHIKV) is an understudied threat to human health. During the 2015 chikungunya epidemic in Managua, Nicaragua, we estimated the ratio of symptomatic to asymptomatic CHIKV infections, which is important for understanding transmission dynamics and the public health impact of CHIKV. This index cluster study identified and monitored persons at risk of infection, enabling capture of asymptomatic infections. We estimated that 31 (49%) of 63 at-risk participants had asymptomatic CHIKV infections, which is significantly outside the 3% to 28% range reported in literature reviews. However, recent seroprevalence studies, including two large pediatric cohort studies in the same setting, had also found percentages of inapparent infections outside the 3% to 28% range. Bayesian and simulation analyses, informed by a systematic literature search, revealed that the percentage of inapparent infections in epidemic settings varies by CHIKV phylogenetic lineage. Our study quantifies and provides the first epidemiological evidence that chikungunya epidemic characteristics are strongly influenced by CHIKV lineage.
Keywords: Bayesian analysis; S:A ratio; chikungunya virus; epidemics; index cluster study; lineage.
Copyright © 2019 American Society for Microbiology.
Figures








Similar articles
-
Seroprevalence of Anti-Chikungunya Virus Antibodies in Children and Adults in Managua, Nicaragua, After the First Chikungunya Epidemic, 2014-2015.PLoS Negl Trop Dis. 2016 Jun 20;10(6):e0004773. doi: 10.1371/journal.pntd.0004773. eCollection 2016 Jun. PLoS Negl Trop Dis. 2016. PMID: 27322692 Free PMC article.
-
Differences in Transmission and Disease Severity Between 2 Successive Waves of Chikungunya.Clin Infect Dis. 2018 Nov 13;67(11):1760-1767. doi: 10.1093/cid/ciy356. Clin Infect Dis. 2018. PMID: 29697796 Free PMC article.
-
"Kankasha" in Kassala: A prospective observational cohort study of the clinical characteristics, epidemiology, genetic origin, and chronic impact of the 2018 epidemic of Chikungunya virus infection in Kassala, Sudan.PLoS Negl Trop Dis. 2021 Apr 30;15(4):e0009387. doi: 10.1371/journal.pntd.0009387. eCollection 2021 Apr. PLoS Negl Trop Dis. 2021. PMID: 33930028 Free PMC article.
-
Chikungunya virus infection in Indonesia: a systematic review and evolutionary analysis.BMC Infect Dis. 2019 Mar 12;19(1):243. doi: 10.1186/s12879-019-3857-y. BMC Infect Dis. 2019. PMID: 30866835 Free PMC article.
-
Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries.J Biomed Sci. 2021 Dec 2;28(1):84. doi: 10.1186/s12929-021-00778-8. J Biomed Sci. 2021. PMID: 34857000 Free PMC article. Review.
Cited by
-
Longitudinal analysis of post-acute chikungunya-associated arthralgia in children and adults: A prospective cohort study in Managua, Nicaragua (2014-2018).PLoS Negl Trop Dis. 2024 Feb 28;18(2):e0011948. doi: 10.1371/journal.pntd.0011948. eCollection 2024 Feb. PLoS Negl Trop Dis. 2024. PMID: 38416797 Free PMC article.
-
Silent circulation of Chikungunya virus among pregnant women and newborns in the Western Brazilian Amazon before the first outbreak of chikungunya fever.Rev Inst Med Trop Sao Paulo. 2022 Apr 4;64:e25. doi: 10.1590/S1678-9946202264025. eCollection 2022. Rev Inst Med Trop Sao Paulo. 2022. PMID: 35384956 Free PMC article.
-
High-resolution spatiotemporal analysis of chikungunya epidemics between 2019 and 2020 in Salvador, Brazil: a municipality-level transmission dynamics study.Lancet Reg Health Am. 2025 Jan 24;43:101003. doi: 10.1016/j.lana.2025.101003. eCollection 2025 Mar. Lancet Reg Health Am. 2025. PMID: 39925861 Free PMC article.
-
Estimating chikungunya virus transmission parameters and vector control effectiveness highlights key factors to mitigate arboviral disease outbreaks.PLoS Negl Trop Dis. 2022 Mar 4;16(3):e0010244. doi: 10.1371/journal.pntd.0010244. eCollection 2022 Mar. PLoS Negl Trop Dis. 2022. PMID: 35245304 Free PMC article.
-
Chikungunya Immunopathology as It Presents in Different Organ Systems.Viruses. 2022 Aug 16;14(8):1786. doi: 10.3390/v14081786. Viruses. 2022. PMID: 36016408 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention. 2015. Chikungunya virus: clinical evaluation and disease. Centers for Disease Control and Prevention, Atlanta, GA.
-
- Teo T-H, Her Z, Tan JJL, Lum F-M, Lee WWL, Chan Y-H, Ong R-Y, Kam Y-W, Leparc-Goffart I, Gallian P, Rénia L, de Lamballerie X, Ng LFP. 2015. Caribbean and La Réunion chikungunya virus isolates differ in their capacity to induce proinflammatory Th1 and NK cell responses and acute joint pathology. J Virol 89:7955–7969. doi:10.1128/JVI.00909-15. - DOI - PMC - PubMed
-
- Langsjoen RM, Haller SL, Roy CJ, Vinet-Oliphant H, Bergren NA, Erasmus JH, Livengood JA, Powell TD, Weaver SC, Rossi SL. 2018. Chikungunya virus strains show lineage-specific variations in virulence and cross-protective ability in murine and nonhuman primate models. mBio 9:e02449-17. doi:10.1128/mBio.02449-17. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical